Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/16002
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Xing, Zhou | - |
dc.contributor.author | Khera, Amandeep | - |
dc.date.accessioned | 2014-10-01T20:16:15Z | - |
dc.date.available | 2014-10-01T20:16:15Z | - |
dc.date.issued | 2014-11 | - |
dc.identifier.uri | http://hdl.handle.net/11375/16002 | - |
dc.description.abstract | Background: Mycobacterium tuberculosis (M.tb) is the causative pathogen of tuberculosis (TB) that is currently the leading cause of death from a bacterial infection. The only licensed vaccine against tuberculosis is the Bacille Calmette-Guérin (BCG) vaccine which fails to effectively protect against adult pulmonary TB. For this reason, efforts have focused on developing novel vaccine platforms to boost BCG-induced immunity. In this regard, a human adenovirus serotype 5 expressing the mycobacterial secreted antigen Ag85A (AdHu5Ag85A) vaccine developed in our lab has been evaluated in a phase I clinical trial. It was shown to boost and elicit lasting T cell responses in BCG-vaccinated volunteers. Although inducing a strong type I T cell mediated immunity by this vaccine is crucial for protection, the role of vaccine-induced B cell responses in protecting against M.tb infection remains poorly understood. Recent studies have shown B cells to contribute to protection by modulating T cell immunity during intracellular bacterial infections. Therefore, we hypothesize that AdHu5Ag85A vaccination also induces antigen-specific B cell responses and such B cells have an immunomodulatory effect on vaccine-induced T cell immunity. Methods: We compared antigen specific T cell and antibody responses in wild type (WT) Balb/c mice with B cell deficient (Jh-/-) mice after intranasal AdHu5Ag85A vaccination. Results: Interim data has demonstrated that AdHu5Ag85A induces antigen specific antibodies. In the absence of B cells, AdHu5Ag85A vaccination resulted in reduced Ag85A CD8+ T cells within the BAL compared to WT. Importantly, this correlated with impaired protection against pulmonary M.tb infection. The study is ongoing to examine the mechanisms by which B cells modulate these T cell responses. Conclusion: These data suggest that B cells are required for optimal protective T cell responses following AdHu5Ag85A respiratory mucosal vaccination against M.tb infection. | en_US |
dc.language.iso | en | en_US |
dc.title | The role of B cells in respiratory mucosal AdHu5Ag85A vaccine-induced immunity against tuberculosis | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | Medical Sciences (Molecular Virology and Immunology Program) | en_US |
dc.description.degreetype | Thesis | en_US |
dc.description.degree | Master of Science (MSc) | en_US |
Appears in Collections: | Open Access Dissertations and Theses |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Amandeep Khera MSc thesis FINAL.pdf | 1.59 MB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.